Prostate cancer awareness gets a huge boost on Super Bowl Sunday when a new ad featuring several of the NFL’s greatest all-time players premieres during the most watched football game of the year.
Improvements in the PSA screening process make it worth another look.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...
Life Line Prostate Cancer Screening Program offers comprehensive PSA testing for men 50+ through over 14,000 convenient locations nationwide. With packages starting at $159 and specialized men's ...
Add Yahoo as a preferred source to see more of our stories on Google. The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most common ...
Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by age 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that new data from a phase 3 trial of the multi-center, randomized ...
Add Yahoo as a preferred source to see more of our stories on Google. New research has found 'wide variation' in the use of prostate cancer testing across the UK. (Getty Images) A new at-home spit ...
STAMPEDE study analysis providing new predictive evidence in clinically very high-risk, nonmetastatic disease to be presented at ESMO ...
A prostate cancer oral presentation will provide the first evidence that the Decipher Prostate test predicts benefit from adding abiraterone to androgen deprivation therapy for patients with ...
LR+ = positive likelihood ratio; LR– = negative likelihood ratio; PSA = prostate-specific antigen; PSE = EpiSwitch prostate screening. *—Binary PSA is defined as a simple test using a fixed cutoff ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results